Leanne Dumeny

Leanne Dumeny

Auto-generated profile, based on publicly available information

Leanne Dumeny

Genetics Institute, University of Florida , Gainesville, Florida , USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 December 2018 in Journal of American College Health
Verified
Journal Article
Closed access
TJTyler G. James
Tyler G. James
MSMeagan K. Sullivan
Meagan K. Sullivan
LDLeanne Dumeny
Leanne Dumeny
KLKatherine Lindsey
Katherine Lindsey
JCJeeWon Cheong
JeeWon Cheong
GNGuy Nicolette
Guy Nicolette
Objective: Health literacy and health insurance literacy affect healthcare utilization. The purpose of this study was to determine the relation between health insurance knowledge, self-efficacy, and student healthcare utilization in the past year. Participants: A random sample of 1,450 respondents, over the age of 18, attending a public university in the southeastern United States completed a survey in March 2017. Methods: A model was constructed to test the effect of health insurance self-efficacy on the relation between knowledge and healthcare utilization in the past year. Results: Health insurance knowledge (M = 5.8, range 0–10) and self-efficacy (M = 2.48, range 1–4) were low. Self-efficacy was a significant moderator when explaining healthcare utilization in the past year. Conclusions: College students have low knowledge and self-efficacy regarding health insurance. These findings can be used for developing policies and self-efficacy-based health education programs that may increase student healthcare utilization.

12 October 2021 in The Pharmacogenomics Journal
Verified
Journal Article
Closed access
PDF file
LGLeonardo A. Guerra
Leonardo A. Guerra
CLChristelle Lteif
Christelle Lteif
MAMeghan J. Arwood
Meghan J. Arwood
CMCaitrin W. McDonough
Caitrin W. McDonough
LDLeanne Dumeny
Leanne Dumeny
JDJulio D. Duarte
Julio D. Duarte

20 March 2018 in Journal of the American Heart Association
Verified
Journal Article
Open access
SSSonal Singh
Sonal Singh
CMCaitrin W. McDonough
Caitrin W. McDonough
YGYan Gong
Yan Gong
WAWael Alghamdi
Wael Alghamdi
MAMeghan J. Arwood
Meghan J. Arwood
JJJulie A. Johnson
Julie A. Johnson
Background: Thiazide and thiazide‐like diuretics are first‐line medications for treating uncomplicated hypertension. However, their use has been associated with adverse metabolic events, including hyperglycemia and incident diabetes mellitus, with incompletely understood mechanisms. Our goal was to identify genomic variants associated with thiazide‐like diuretic/chlorthalidone‐induced glucose change. Methods and Results: Genome‐wide analysis of glucose change after treatment with chlorthalidone was performed by race among the white (n=175) and black (n=135) participants from the PEAR ‐2 (Pharmacogenomic Evaluation of Antihypertensive Responses‐2). Single‐nucleotide polymorphisms with P <5×10 −8 were further prioritized using in silico analysis based on their expression quantitative trait loci function. Among blacks, an intronic single‐nucleotide polymorphism (rs9943291) in the HMGCS 2 was associated with increase in glucose levels following chlorthalidone treatment (ß=12.5; P =4.17×10 −8 ). G‐allele carriers of HMGCS 2 had higher glucose levels (glucose change=+16.29 mg/dL) post chlorthalidone treatment compared with noncarriers of G allele (glucose change=+2.80 mg/dL). This association was successfully replicated in an independent replication cohort of hydrochlorothiazide‐treated participants from the PEAR study (ß=5.54; P =0.023). A meta‐analysis of the 2 studies was performed by race in Meta‐Analysis Helper, where this single‐nucleotide polymorphism, rs9943291, was genome‐wide significant with a meta‐analysis P value of 3.71×10 −8 . HMGCS 2 , a part of the HMG ‐CoA synthase family, is important for ketogenesis and cholesterol synthesis pathways that are essential in glucose homeostasis. Conclusions: These results suggest that HMGCS 2 is a promising candidate gene involved in chlorthalidone and Hydrochlorothiazide (HCTZ)‐induced glucose change. This may provide insights into the mechanisms involved in thiazide‐induced hyperglycemia that may ultimately facilitate personalized approaches to antihypertensive selection for hypertension treatment. Clinical Trial Registration: URL : http://www.clinicaltrials.gov . Unique identifiers: NCT 00246519 and NCT 01203852.

7 May 2020 in JCI Insight
Verified
Journal Article
Open access
MSMathew Sebastian
Mathew Sebastian
CHChu J. Hsiao
Chu J. Hsiao
HFHunter S. Futch
Hunter S. Futch
RERobert S. Eisinger
Robert S. Eisinger
LDLeanne Dumeny
Leanne Dumeny
MBMark L. Brantly
Mark L. Brantly
BACKGROUND: Obesity has been associated with attenuated vaccine responses and an increased risk of contracting pneumococcal pneumonia, but no study to our knowledge has assessed the impact of obesity and genetics on 23-valent pneumococcal vaccine (PPSV23) efficacy. We assessed the relationship of obesity (primary analysis) and stimulator of interferon genes ( STING1 ) genotype (secondary analysis) on PPSV23 efficacy. METHODS: Nonobese (BMI 22–25 kg/m 2 ) and obese participants (BMI ≥30 kg/m 2 ) were given a single dose of PPSV23. Blood was drawn immediately prior to and 4–6 weeks after vaccination. Serum samples were used to assess PPSV23-specific antibodies. STING1 genotypes were identified using PCR on DNA extracted from peripheral blood samples. RESULTS: Forty-six participants were categorized as nonobese ( n = 23; 56.5% women; mean BMI 23.3 kg/m 2 ) or obese ( n = 23; 65.2% women; mean BMI 36.3 kg/m 2 ). Obese participants had an elevated fold change in vaccine-specific responses compared with nonobese participants ( P < 0.0001). The WT STING1 group ( R232/R232 ) had a significantly higher PPSV23 response than individuals with a single copy of HAQ-STING1 regardless of BMI ( P = 0.0025). When WT was assessed alone, obese participants had a higher fold serotype-specific response compared with nonobese participants ( P < 0.0001), but no difference was observed between obese and nonobese individuals with 1 HAQ allele ( P = 0.693). CONCLUSIONS: These observations demonstrate a positive association between obesity and PPSV23 efficacy specifically in participants with the WT STING1 genotype. TRIAL REGISTRATION: ClinicalTrials.gov NCT02471014. FUNDING: This research was supported by the NIH and the University of Florida MD-PhD Training Program.

13 September 2016 in Annals of Biomedical Engineering
Verified
Journal Article
Closed access
PDF file
BKBenjamin Klein
Benjamin Klein
ADAnthony Destephens
Anthony Destephens
LDLeanne Dumeny
Leanne Dumeny
QHQiongyao Hu
Qiongyao Hu
YHYong He
Yong He
SBScott A. Berceli
Scott A. Berceli

24 August 2022 in American Journal of Hypertension
Verified
Journal Article
Closed access
PDF file
CHChu J Hsiao
Chu J Hsiao
LDLeanne Dumeny
Leanne Dumeny
ABAdam P Bress
Adam P Bress
DJDayna A Johnson
Dayna A Johnson
DSDaichi Shimbo
Daichi Shimbo
CMConnie J Mulligan
Connie J Mulligan
In the United States, hypertension disproportionately afflicts over half of African American adults, many of whom also experience racial discrimination. Understanding gene × discrimination effects may help explain racial disparities in hypertension. We tested for the main effects and interactive effects of 5 candidate single nucleotide polymorphisms (SNPs: rs2116737, rs11190458, rs2445762, rs2597955, and rs2416545) and experiences of discrimination on blood pressure (BP) in African Americans not taking antihypertensive medications in the Jackson Heart Study from Mississippi (n = 2,933). Multiple linear regression models assumed an additive genetic model and adjusted for ancestry, age, sex, body mass index, education, and relatedness. We additionally tested recessive and dominant genetic models. Discrimination was significantly associated with higher diastolic BP (P = 0.003). In contrast, there were no main effects of any SNP on BP. When analyzing SNPs and discrimination together, SGCD (Sarcoglycan Delta; rs2116737) demonstrated a gene × environment interaction. Specifically, an SGCD × Discrimination interaction was associated with systolic BP (β =1.95, P = 0.00028) in a recessive model. Participants carrying a T allele, regardless of discrimination experiences, and participants with a GG genotype and high experiences of discrimination had higher systolic BP than participants with a GG genotype and low experiences of discrimination. This finding suggests the SGCD GG genotype may have a protective effect on systolic BP, but only in a setting of low discrimination. The inclusion of culturally relevant stressors, like discrimination, may be important to understand the gene-environment interplay likely underlying complex diseases with racial health inequities.